NYSE:HIMS

Hims & Hers Health - Class A Stock Insider Trading

Consumer Defensive > Household & Personal Products

Buy HIMS

*Your capital is at risk

$27.77

+0.730 (+2.70%)

At Close: Jul 31, 2026

Hims & Hers Health - Class A Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -6.15. In total, the insiders bought 1.66M and sold 544.74K HIMS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-6.15
● Buy	1.66M shares
● Sell	544.74K shares
80% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence Jun 15, 2026 Analysis Breakdown: Weakened by a contradictory negative Insider Power Score. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (80% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 15, 2026 Buy	Class A Common Stock M-Exempt	Carroll Patrick Harrison Chief Medical Officer	Officer	25 926 Value: $782.2K
Jun 15, 2026 Buy	Class A Common Stock M-Exempt	Elshenawy Mohamed CTO	Officer	282 597 Value: $8.53M
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Elshenawy Mohamed CTO	Officer	23 513 Value: $709.4K
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Elshenawy Mohamed CTO	Officer	259 084 Value: $7.82M
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Dudum Andrew Chief Executive Officer	CEO / President	35 446 Value: $1.07M
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Dudum Andrew Chief Executive Officer	CEO / President	19 150 Value: $577.8K
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Dudum Andrew Chief Executive Officer	CEO / President	25 865 Value: $780.3K
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Dudum Andrew Chief Executive Officer	CEO / President	74 530 Value: $2.25M
Jun 15, 2026 Sell	Class A Common Stock F-InKind	Dudum Andrew Chief Executive Officer	CEO / President	85 632 Value: $2.58M
Jun 15, 2026 Buy	Class A Common Stock M-Exempt	Manuel Anja Director	Director	10 040 Value: $302.9K
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Manuel Anja Director	Director	10 040 Value: $302.9K
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Payne Christopher D Director	Director	10 040 Value: $302.9K
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Payne Christopher D Director	Director	647 Value: $19.5K
Jun 15, 2026 Buy	Class A Common Stock M-Exempt	Carroll Patrick Harrison Chief Medical Officer	Officer	435 Value: $13.1K
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Carroll Patrick Harrison Chief Medical Officer	Officer	435 Value: $13.1K
Jun 15, 2026 Buy	Class A Common Stock M-Exempt	Wells David B Director	Director	957 Value: $28.9K
Jun 15, 2026 Buy	Restricted Stock Unit M-Exempt	Wells David B Director	Director	957 Value: $28.9K
Jun 15, 2026 Buy	Class A Common Stock M-Exempt	Payne Christopher D Director	Director	647 Value: $19.5K
Jun 15, 2026 Buy	Class A Common Stock M-Exempt	Payne Christopher D Director	Director	10 040 Value: $302.9K
Jun 11, 2026 Buy	Restricted Stock Unit M-Exempt	Pendarvis Christiane Director	Director	3 656 Value: $105.5K
Jun 11, 2026 Buy	Class A Common Stock M-Exempt	Manuel Anja Director	Director	3 656 Value: $105.5K
Jun 11, 2026 Buy	Restricted Stock Unit M-Exempt	Manuel Anja Director	Director	3 656 Value: $105.5K
Jun 11, 2026 Buy	Class A Common Stock M-Exempt	Payne Christopher D Director	Director	3 656 Value: $105.5K
Jun 11, 2026 Buy	Restricted Stock Unit M-Exempt	Perez Garcia Andrea G Director	Director	3 656 Value: $105.5K
Jun 11, 2026 Buy	Class A Common Stock M-Exempt	Carroll Patrick Harrison Chief Medical Officer	Officer	3 656 Value: $105.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT HIMS & HERS HEALTH INC - CLASS A

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmeti...

Read Full Profile Here